Get Sample Pages - India Pharmaceutical Industry Trends & Future Outlook 2030

India Pharmaceutical Market Research Report: Forecast (2025-2030)

India Pharmaceutical Market - By Product Type (Prescription Drugs, Over-the-counter Drugs, Biologics & Biosimilar, [Monoclonal Antibodies, Hormones, Vaccines]), By Distribution Cha......nnel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals and Clinics, Retail Consumers, Research & Academic Institutes), and others Read more

Healthcare
Aug 2025
Pages 125
Report Format: PDF, Excel, PPT

Market Definition

Pharmaceutical is an industry related to the innovation, discovery, manufacturing, development, and marketing of medications and drugs, which are used to treat and cure diseases.

Market Insights & Analysis: India Pharmaceuticals Market (2025-30):

The India Pharmaceutical Market size was valued at around USD 53.29 billion in 2025 and is projected to reach USD 92.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.62% during the forecast period, i.e., 2025-30. The India Pharmaceutical Market is significantly growing due to several growth factors, including the growing burden of chronic diseases such as diabetes, cardiovascular diseases, & respiratory diseases, the rising healthcare requirements, the active government support, the rapid adoption of green and sustainable manufacturing of pharmaceutical products, etc. One of the most prominent growth factors is the rising global demand for Indian pharmaceuticals due to their affordable costs, approval by global regulators like the WHO and the USFDA. India has started to export pharmaceutical products such as drugs and vaccines to more than 200 countries, including the United States, Europe, and African countries.

Additionally, the Indian government is also encouraging the pharmaceutical industry to substantially grow in the country by allocating heavy funds under various policies such as the Production Linked Incentive Scheme and the Pharma Vision 2020. Also, the improved trade relations between India and other countries are increasing the market potential, as these relations allow the Indian Pharmaceutical Markets to enter with zero percent tariffs in foreign markets.

Moreover, the adoption of sustainable practices in the synthesis of various drugs and the active ingredients to reduce pollution and to safeguard the environmental & public health due to rising environmental concerns is positively transforming this market. However, intense competition from the companies producing generic drugs and the regulatory hurdles are restraining the market growth & expansion.

India Pharmaceuticals Market Scope:

Category	Segments
By Product Type	Prescription Drugs, Over-the-counter Drugs, Biologics & Biosimilar, [Monoclonal Antibodies, Hormones, Vaccines
By Distribution Channel	Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By End User	Hospitals and Clinics, Retail Consumers, Research & Academic Institutes), and others

India Pharmaceuticals Market Driver:

Rising Chronic Diseases – The pharmaceutical demand is rapidly growing due to the high severity of chronic diseases in the country, such as diabetes, cardiovascular diseases, tuberculosis, respiratory diseases, and many more. For instance, India has over 100 million individuals suffering from diabetes, while above 25% of the annual deaths in India are due to the rising cardiovascular diseases. Additionally, India has the highest tuberculosis patients globally, accounting for approximately 30% of the world’s total TB cases. For instance, in 2023, about 2.4 million new cases of TB were added in India.

Moreover, kidney diseases are also highly prevalent in India, affecting around 200 million Indians. The high burden of these diseases is increasing the demand for high-quality medications and drugs for the early treatment of diseases. Consequently, over 60,000 different drugs and pharmaceutical formulations are being produced annually in India, thus significantly contributing to the growth & development of the pharmaceutical industry in India.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
India Pharmaceuticals Market Regulations, Policies & Standards
India Pharmaceuticals Market Trends & Developments
India Pharmaceuticals Market Dynamics
1. Growth Drivers
2. Challenges
India Pharmaceuticals Market Hotspots & Opportunities
India Pharmaceuticals Market Value Chain Analysis
India Pharmaceuticals Market Outlook, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Product Type
    1. Prescription Drugs- Market Size & Forecast 2020-2030, USD Million
    2. Over-the-counter Drugs- Market Size & Forecast 2020-2030, USD Million
    3. Biologics & Biosimilar- Market Size & Forecast 2020-2030, USD Million
      1. Monoclonal Antibodies- Market Size & Forecast 2020-2030, USD Million
      2. Hormones- Market Size & Forecast 2020-2030, USD Million
      3. Vaccines- Market Size & Forecast 2020-2030, USD Million
  2. By Distribution Channel
    1. Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
    2. Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
    3. Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
  3. By End User
    1. Hospitals and Clinics- Market Size & Forecast 2020-2030, USD Million
    2. Retail Consumers- Market Size & Forecast 2020-2030, USD Million
    3. Research & Academic Institutes- Market Size & Forecast 2020-2030, USD Million
  4. By Region
    1. North
    2. South
    3. East
    4. West
    5. Central
  5. By Competitors
    1. Competition Characteristics
    2. Market Share & Analysis
India Prescription Drugs Market Outlook, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  2. By End User- Market Size & Forecast 2020-2030, USD Million
India Over-the-Counter Drugs Market Outlook, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  2. By End User- Market Size & Forecast 2020-2030, USD Million
India Biologics & Biosimilar Market Outlook, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  2. By End User- Market Size & Forecast 2020-2030, USD Million
India Pharmaceuticals Market Key Strategic Imperatives for Growth & Success
Competitive Outlook
1. Company Profiles
  1. Sun Pharmaceutical Industries Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Dr. Reddy’s Laboratories Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Cipla Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Lupin Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Aurobindo Pharma Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Zydus Lifesciences Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Torrent Pharmaceuticals Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Glenmark Pharmaceuticals Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Alembic Pharmaceuticals Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Biocon Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *